PIK3CA and colorectal carcinoma: Additionally, mutations in EGFR downstream signaling pathways, including KRAS, BRAF, and PIK3CA, are crucial for metastatic CRC progression [48], while abnormalities in the JAK2/STAT3 pathway disrupt apoptosis.